Nalaganje...
Primary resistance to osimertinib despite acquired T790M
Current National Comprehensive Cancer Network (NCCN) guidelines suggest plasma‐based testing (liquid biopsy) for T790M in epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung carcinoma (NSCLC) with acquired resistance to first‐/second‐generation EGFR tyrosine kinase inhibitors (TKIs)....
Shranjeno v:
| izdano v: | Respirol Case Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002899/ https://ncbi.nlm.nih.gov/pubmed/32042433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.532 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|